Forecasts of explosive AI progress predict that what researchers call recursive self-improvement is on the horizon.  But a new study suggests that it might take a while for us to get there. The ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Mitch McConnell’s health status has become such a big mystery that even Republican elected officials and MAGA influencers are asking for proof that the Kentucky senator is alive and (relatively) well.

Emergency responders took Sen. Mitch McConnell to an ambulance on a stretcher after being called to his home last month for a report of an unconscious person, according to new video of the incident ...

Body camera video shows the moments a deputy responded after a woman was fatally attacked by an alligator while swimming in a Florida river. The brief video shows a deputy arriving at the scene at the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. It's a suitably packed month on Prime Video as the streamer speeds ...

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

JAVA CENTER, N.Y. — The search for a missing boater on Java Lake has ended in tragedy. Robert Fuller, 46, of Java Lake, NY was found dead Saturday night, according to the Wyoming County Sheriff's ...

The Wyoming County Sheriff's Office said 911 dispatchers received a call at 6:50 p.m. Friday reporting a capsized boat on Java Lake in the Town of Java. Two people were reported to have entered the ...

Recursion Pharmaceuticals, Inc. is advancing REC-1245, an RBM39 degrader, in the DHALIA trial in solid tumors, with Q1'26 earnings noting no dose-limiting toxicities so far. Initial DHALIA trial data ...